Yoshimura Kazuhiro 吉村一宏

… Alternative Names

YOSHIMURA Kazuhiro 吉村一宏

Less

Researcher Number	20283757
Other IDs
Affiliation (Current)	2025: 近畿大学, 医学部, 教授
Affiliation (based on the past Project Information) *help	2014 – 2018: 近畿大学, 医学部, 教授 2010 – 2013: 近畿大学, 医学部, 准教授 2003 – 2004: 大阪大学, 医学系研究科, 講師 2002: 大阪大学, 医学系研究科, 助手
Review Section/Research Field	Principal Investigator Urology Except Principal Investigator Urology
Keywords	Principal Investigator Fibronectin / HGF / Calcium oxalate / Urolithiasis / GAGS / クエン酸 / LDH / アポトーシス / 蓚酸カルシウム結晶 / 蓚酸 / 蓚酸カルシウム / 尿路結石症 … More Except Principal Investigator … More 免疫療法 / ペプチドワクチン / 腎細胞癌 / PDL-1 / HIF-1 / EPOR / 癌ワクチン療法 / 腎細胞がん / 癌ワクチン / HLA-A2 / がんワクチン / HLA-A24 / ワクチン療法 / ペプチド / VEGFR / CA9 Less

Development of the HLA-A2 restricted multi-peptides vaccine for renal cell carcinoma.
- Principal Investigator
  
  UEMURA Hirotsugu
- Project Period (FY)
  2016 – 2018
- Research Category
  
  Grant-in-Aid for Scientific Research (B)
- Research Field
  
  Urology
- Research Institution
  Kindai University
Development of multi-peptide tumor vaccine for renal cell carcinoma
- Principal Investigator
  
  UEMURA Hirotsugu
- Project Period (FY)
  2013 – 2015
- Research Category
  
  Grant-in-Aid for Scientific Research (B)
- Research Field
  
  Urology
- Research Institution
  Kinki University
Development of tailor made peptide vaccines for renal cell carcinoma
- Principal Investigator
  
  UEMURA Hirotsugu
- Project Period (FY)
  2010 – 2012
- Research Category
  
  Grant-in-Aid for Scientific Research (B)
- Research Field
  
  Urology
- Research Institution
  Kinki University
Investigation of inhibitors in crystal-cell injury of renal tubular epithelium by oxalate and calcium oxalatePrincipal Investigator
- Principal Investigator
  
  YOSHIMURA Kazuhiro, 三宅修
- Project Period (FY)
  2002 – 2004
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Urology
- Research Institution
  Osaka University

All 2017 2016 2015 2014 2013 2012 Other

All Journal Article Presentation

[Journal Article] Hypoxia-inducing factor (HIF)-1α-derived peptide capable of inducing cancer-reactive cytotoxic T lymphocytes from HLA-A24+ patients with renal cell carcinoma.2017
- Author(s)
  1.Minami T, Matsumura N, Sugimoto K, Shimizu N, De Velasco M, Nozawa M, Yoshimura K, Harashima N, Harada M, Uemura H.
- Journal Title
  
  Int Immunopharmacol.
  
  Volume: 44 Pages: 197-202
- DOI
  10.1016/j.intimp.2017.01.014
- Peer Reviewed / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-16H05466, KAKENHI-PROJECT-17K07217
[Journal Article] Identification of programmed death ligand 1-derived peptides capable of inducing cancer-reactive cytotoxic T lymphocytes from HLA-A24+ patients with renal cell carcinoma2015
- Author(s)
  Minami T., Minami T., Shimizu N., Yamamoto Y., De Velasco MA., Nozawa M., Yoshimura K., Harashima N., Harada M., Uemura H.
- Journal Title
  
  Journal of Immunotherapy
  
  Volume: 38 (7) Issue: 7 Pages: 285-291
- DOI
  10.1097/cji.0000000000000090
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-25430150, KAKENHI-PROJECT-25293336
[Journal Article] New polycomb group protein enhancer of zeste homolog (EZH) 2-derived peptide with the potential to induce cancer-reactive cytotoxic T lymphocytes in prostate cancer patients with HLA-A3 supertype alleles2015
- Author(s)
  Minami T, Minami T, Shimizu N, Yamamoto Y, De Velasco M A, Nozawa M, Yoshimura K, Harashima N, Harada M, Uemura H.
- Journal Title
  
  International Immunopharmacology
  
  Volume: 26 Issue: 1 Pages: 133-138
- DOI
  10.1016/j.intimp.2015.03.023
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-24501331, KAKENHI-PROJECT-24592416, KAKENHI-PROJECT-25430150, KAKENHI-PROJECT-25293336
[Journal Article] Identification of erythropoietin receptor-derived peptides having the potential to induce cancer-reactive cytotoxic T lymphocytes from HLA-A24+ patients with renal cell carcinoma.2014
- Author(s)
  Minami T, Minami T, Shimizu N, Yamamoto Y, De Velasco M, Nozawa M, Yoshimura K, Harashima N, Harada M, Uemura H
- Journal Title
  
  Int Immunopharmacol.
  
  Volume: 20 Pages: 59-65
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-25293336
[Journal Article] Identification of erythropoietin receptor-derived peptides having the potential to induce cancer-reactive cytotoxic T lymphocytes from HLA-A24(+) patients with renal cell carcinoma.2014
- Author(s)
  Minami T, Minami T, Shimizu N, Yamamoto Y, De Velasco M, Nozawa M, Yoshimura K, Harashima N, Harada M, Uemura H.
- Journal Title
  
  Int Immunopharmacol.
  
  Volume: 20 Pages: 59-65
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-25293336
[Journal Article] Phase I clinical trial of human vascular endothelial growth factor receptor 1 peptide vaccines for patients with metastatic renal cell carcinoma.2013
- Author(s)
  Yoshimura K, Minami T, Nozawa M, Uemura H.
- Journal Title
  
  Br J Cancer.
  
  Volume: 108 Issue: 6 Pages: 1260-1266
- DOI
  10.1038/bjc.2013.90
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22390305, KAKENHI-PROJECT-25293336
[Journal Article] Phase I clinical trial of human vascular endothelial growth factor receptor 1 peptide vaccines for patients with metastatic renal cell carcinoma2013
- Author(s)
  Yoshimura K, Minami T, Nozawa M, Uemura H
- Journal Title
  
  Br J Cancer
  
  Volume: 108(6) Pages: 1260-6
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22390305
[Journal Article] Role of vaccine therapy for renal cell carcinoma in the era of targeted therapy.2013
- Author(s)
  Yoshimura K, Uemura H. Yoshimura K, Uemura H.
- Journal Title
  
  Int J Urol.
  
  Volume: - Issue: 8 Pages: 1-10
- DOI
  10.1111/iju.12147
- NAID
  10031190532
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22390305, KAKENHI-PROJECT-25293336
[Presentation] HLA-A24陽性腎細胞癌症例においてCancer-reactive cytotoxic T lymphocytes を誘導しうるEpoR, PD-L1ペプチドの同定2016
- Author(s)
  南　高文、南　知子、清水信貴、山本　豊、Marco De Velasco、野澤昌弘、吉村一宏、
- Organizer
  第104回日本泌尿器科学会総会
- Place of Presentation
  仙台国際センター、東北大学記念会館、仙台市
- Year and Date
  2016-04-23
- Data Source
  KAKENHI-PROJECT-16H05466
[Presentation] 去勢抵抗性前立腺癌に対する免疫療法2015
- Author(s)
  吉村一宏、植村天受　ほか
- Organizer
  第65回　日本泌尿器科学会中部総会
- Place of Presentation
  長良川国際会議場、岐阜都ホテル
- Year and Date
  2015-10-23
- Data Source
  KAKENHI-PROJECT-25293336
[Presentation] Clinical role of MHC-class I peptide vaccines for metastatic renal cell carcinoma2013
- Author(s)
  T Minami, T Minami, N Shimizu, Y Yamamoto, M De Velasco, T Hayashi, M Nozawa, K Yoshimura, T Ishii, H Uemura
- Organizer
  28th Annual EAU Congress
- Place of Presentation
  Milan
- Year and Date
  2013-03-18
- Data Source
  KAKENHI-PROJECT-22390305
[Presentation] HLA-A24 陽性腎細胞癌患者におけるcancer-reactive CTLs を誘導し得るEpoR 抗原由来ペプチドの同定2012
- Author(s)
  南高文、南知子、大関孝之、デベラスコマルコ、清水信貴、山本豊、辻秀憲、野澤昌弘、吉村一宏、植村天受
- Organizer
  第71回日本癌学会学術総会
- Place of Presentation
  札幌市
- Year and Date
  2012-09-19
- Data Source
  KAKENHI-PROJECT-22390305
[Presentation] 転移性腎がんに対するMHC クラスI ペプチドワクチン療法の役割2012
- Author(s)
  植村天受、吉村一宏、南高文、デベラスコマルコ
- Organizer
  第71回日本癌学会学術総会
- Place of Presentation
  札幌市
- Year and Date
  2012-09-19
- Data Source
  KAKENHI-PROJECT-22390305
[Presentation] The Clinical role of peptide vaccines for castration-resistant prostate cancer2012
- Author(s)
  Takafumi Minami, Takahiro Kimura, Masahiro Nozawa, Kazuhiro Yoshimura, Toru Nakagawa, Akira Yamada, Kyogo Ito, Hiroyuki Fujimoto, Shi Egawa, Hirotsugu Uemura
- Organizer
  The 10th Annual Meeting of Japanese Society of Medical Oncology
- Place of Presentation
  Osaka
- Year and Date
  2012-07-18
- Data Source
  KAKENHI-PROJECT-22390305
[Presentation] 転移性腎癌に対するMHCクラスIペプチドワクチン療法の役割
- Author(s)
  植村天受、吉村一宏ほか
- Organizer
  第71回日本癌学会学術総会
- Place of Presentation
  ロイトン札幌（札幌市）
- Data Source
  KAKENHI-PROJECT-22390305

1. DE VELASCO Marco (20449838)

# of Collaborated Projects: 3 results

# of Collaborated Products: 7 results
2. UEMURA Hirotsugu (90213397)

# of Collaborated Projects: 3 results

# of Collaborated Products: 12 results
3. MINAMI Takafumi (70340809)

# of Collaborated Projects: 3 results

# of Collaborated Products: 10 results
4. HARADA Mamoru (50260716)

# of Collaborated Projects: 3 results

# of Collaborated Products: 4 results
5. 三宅修 (60273661)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
6. 辻畑正雄 (30335343)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
7. 原嶋奈々江

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results

Yoshimura Kazuhiro 吉村 一宏

YOSHIMURA Kazuhiro 吉村 一宏

Research Projects

Research Products

Co-Researchers

Development of the HLA-A2 restricted multi-peptides vaccine for renal cell carcinoma.

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Development of multi-peptide tumor vaccine for renal cell carcinoma

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Development of tailor made peptide vaccines for renal cell carcinoma

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Investigation of inhibitors in crystal-cell injury of renal tubular epithelium by oxalate and calcium oxalatePrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

[Journal Article] Hypoxia-inducing factor (HIF)-1α-derived peptide capable of inducing cancer-reactive cytotoxic T lymphocytes from HLA-A24+ patients with renal cell carcinoma.2017

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Identification of programmed death ligand 1-derived peptides capable of inducing cancer-reactive cytotoxic T lymphocytes from HLA-A24+ patients with renal cell carcinoma2015

Author(s)

Journal Title

DOI

Data Source

[Journal Article] New polycomb group protein enhancer of zeste homolog (EZH) 2-derived peptide with the potential to induce cancer-reactive cytotoxic T lymphocytes in prostate cancer patients with HLA-A3 supertype alleles2015

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Identification of erythropoietin receptor-derived peptides having the potential to induce cancer-reactive cytotoxic T lymphocytes from HLA-A24+ patients with renal cell carcinoma.2014

Author(s)

Journal Title

Data Source

[Journal Article] Identification of erythropoietin receptor-derived peptides having the potential to induce cancer-reactive cytotoxic T lymphocytes from HLA-A24(+) patients with renal cell carcinoma.2014

Author(s)

Journal Title

Data Source

[Journal Article] Phase I clinical trial of human vascular endothelial growth factor receptor 1 peptide vaccines for patients with metastatic renal cell carcinoma.2013

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Phase I clinical trial of human vascular endothelial growth factor receptor 1 peptide vaccines for patients with metastatic renal cell carcinoma2013

Author(s)

Journal Title

Data Source

[Journal Article] Role of vaccine therapy for renal cell carcinoma in the era of targeted therapy.2013

Author(s)

Journal Title

DOI

NAID

Data Source

[Presentation] HLA-A24陽性腎細胞癌症例においてCancer-reactive cytotoxic T lymphocytes を誘導しうるEpoR, PD-L1ペプチドの同定2016

Author(s)

Organizer

Place of Presentation

Year and Date

Data Source

[Presentation] 去勢抵抗性前立腺癌に対する免疫療法2015

Author(s)

Organizer

Place of Presentation

Year and Date

Data Source

[Presentation] Clinical role of MHC-class I peptide vaccines for metastatic renal cell carcinoma2013

Yoshimura Kazuhiro 吉村一宏

YOSHIMURA Kazuhiro 吉村一宏